Trinity Partners Welcomes Strong 2017 Class of New Hires

Trinity Partners, a global life sciences consulting firm, today announced that it has welcomed its 21st annual class of recent graduates, onboarding 25 new hires. Hailing from top universities across the nation including Harvard, Duke, Vanderbilt, Dartmouth and Williams, these new additions to the company will join practice areas including Strategy Consulting, Advanced Analytics and Primary Market Research.

Trinity provides new hires with a comprehensive onboarding program to ensure they are set up for success, including hands-on sessions facilitated by over 60 percent of our tenured staff; a full client engagement simulation; and discussions focused on acclimating to the industry and general corporate work environment.

“Fostering employee growth and career development is one of Trinity’s top priorities,” said Michelle Adams, HR Director at Trinity Partners. “We are thrilled to welcome this class of new graduates in to a fast-paced work environment where they can learn as they grow, be exposed to new opportunities, and help biopharmaceutical companies tackle their most pressing business challenges.”

Trinity has more than 150 employees with offices in San Francisco, Princeton, New Jersey and New York City. Coming out of a busy first half of 2017, headlined by the release of a whitepaper analyzing the correlation between drug price and value, Trinity is well-positioned to continue to help clients identify opportunities and pain points. The company maintains an unwavering commitment to the development of its employees that drive its continued growth and broadening influence in the life sciences industry.

“No matter the industry or role, it is imperative to get some perspective. We are looking forward to seeing how Trinity’s new team members will be able to approach our unique business from an alternative angle, delivering meaningful and measurable results,” said Dave Fitzhenry, Partner at Trinity Partners.

About Trinity Partners: 
Trinity Partners is a trusted life sciences strategy consulting firm that takes a personalized approach to working with pharmaceutical, biotech, medical device, and diagnostic clients worldwide to create evidence-based solutions that drive business strategy and impact bottom lines. To learn more about our Partners, click here.

Trinity Participates in RACE Cancer Foundation Boston 5K to Support Fight Against Cancer

Trinity employees ran and power-walked to support the battle against cancer at the RACE Cancer Foundation 5K on August 10th in Boston. RACE programs create opportunities to reduce and detect cancer through education, prevention, and screening measures. 100 percent of funds raised at RACE running events benefit organizations such as the Leukemia & Lymphoma Society, Target Cancer Foundation and the Multiple Myeloma Research Foundation. Trinity had a great time meeting other members of the Greater Boston community who are dedicated to helping in the fight against cancer.

Trinity Partners Gives Back at the Community Day Center of Waltham

Last week, Trinity employees spent an afternoon organizing, menu planning, cooking and serving lunch to individuals at the Community Day Center of Waltham. The Day Center, a not-for-profit organization, provides a warm, welcoming place and services for people who are homeless and those who may feel alone and isolated. Trinity encourages all employees to dedicate a portion of their time to volunteer work in the local community.

Pharmaceutical Commerce Speaks with Herman Sanchez About the Evolving Oncology Market

Partner Herman Sanchez recently spoke with Pharmaceutical Commerce about the cancer market and how immune-oncology is revolutionizing the space. Learn more about the rapidly evolving industry here:

Trinity Partners Identifies Value Proposition of Most Expensive Drugs Approved by the FDA from 2014-2016

Trinity Partners today, in tandem with the 22nd Annual International ISPOR Meeting, announced the results of a whitepaper titled, “What We Value: The Proposition Behind the Price.” The authors analyze the costliest drugs to the healthcare system approved by the FDA from 2014-2016 in order to understand the interaction between value and price.  In this industry analysis, Trinity reveals the factors that appear to allow some drugs a higher price point than others and addresses key questions including: What do the most expensive drug launches in the recent past reveal about what our society values? What does the market seem to be willing to pay for?

Download the whitepaper here:

Trinity Partners Attends Life Science Cares Impact Breakfast

Trinity team members attended MassBio’s Life Science Cares Impact Breakfast on May 16, celebrating the industry’s commitment to ending poverty in greater Boston with over 500 life science leaders attended the event. Life Science Cares is a collective effort of the life science industry to eliminate the impact of poverty on our neighbors in the greater Boston area. Through uniting the human and financial resources of life science companies and industry leaders, we support service organizations that do the best work in fighting poverty in our community. Check out our team who attended the gathering!

Trinity Partners Experts to Attend Veeva Summit 2017

Trinity Partners, a leading global life sciences consulting firm, announced that John Gillis will attend Veeva Systems’ 2017 Global Commercial & Medical Summit in Philadelphia from May 7-9. Deemed the “industry’s largest event,” our employees are looking forward to networking with over 1,200 life science professionals and learning more about commercial and medical affairs. Read about the conference here: